1. Home
  2. MYGN vs ISTR Comparison

MYGN vs ISTR Comparison

Compare MYGN & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$4.28

Market Cap

444.2M

Sector

Health Care

ML Signal

N/A

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

N/A

Current Price

$29.81

Market Cap

394.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
ISTR
Founded
1991
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
394.5M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
MYGN
ISTR
Price
$4.28
$29.81
Analyst Decision
Buy
Hold
Analyst Count
7
1
Target Price
$7.64
$31.50
AVG Volume (30 Days)
1.5M
139.0K
Earning Date
05-05-2026
04-20-2026
Dividend Yield
N/A
1.59%
EPS Growth
N/A
4.41
EPS
N/A
0.77
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.86
$66.56
Revenue Next Year
$5.45
$5.18
P/E Ratio
N/A
$38.29
Revenue Growth
2.33
N/A
52 Week Low
$3.53
$17.89
52 Week High
$8.59
$30.50

Technical Indicators

Market Signals
Indicator
MYGN
ISTR
Relative Strength Index (RSI) 48.53 62.47
Support Level $3.53 $28.79
Resistance Level $5.30 $30.45
Average True Range (ATR) 0.32 0.67
MACD 0.02 0.13
Stochastic Oscillator 42.70 74.63

Price Performance

Historical Comparison
MYGN
ISTR

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

Share on Social Networks: